Quick Answer
GLP-1 medications are FDA-approved for teenagers ages 12 and older with obesity. Wegovy (semaglutide) and Saxenda (liraglutide) are approved for adolescent weight management, showing an average 16.1% weight loss at 68 weeks in clinical trials. Safety profiles in teens mirror adult data, with nausea being the most common side effect. These medications should be used alongside lifestyle modifications and under close medical supervision.
Key Points
- FDA-approved options: Wegovy (ages 12+, weekly injection) and Saxenda (ages 12+, daily injection)
- Eligibility: BMI ≥95th percentile for age and sex, or ≥85th percentile with weight-related comorbidities
- Efficacy: 16.1% average weight loss at 68 weeks (vs. 0.6% with placebo) in STEP TEENS trial
- Safety profile: Similar to adults; nausea most common side effect; no new unexpected risks in teens
- Monitoring required: Regular follow-ups for growth, development, mental health, and nutritional status
- Lifestyle component: Must be used with diet, exercise, and behavioral modifications
Products for teens on GLP-1s:
- Water bottle with time markers - encourage hydration
- Protein powder - hit protein goals easily
Statistics
- Adolescent obesity prevalence: 19.7% of youth ages 2-19 in the U.S. (CDC, 2025)
- Treatment success rate: 16.1% average body weight reduction at 68 weeks with semaglutide (STEP TEENS trial, 2024)
- Completion rate: 73% of adolescents completed the 68-week trial (vs. 66% placebo) (STEP TEENS trial, 2024)
- Quality of life improvement: Significant improvement in physical functioning scores (p<0.001) (STEP TEENS trial, 2024)
Medical Review
This article was reviewed by the GLP Spot Medical Review Board, a team of licensed healthcare professionals specializing in pediatric endocrinology and adolescent medicine. Our reviewers ensure all information is evidence-based, current with 2026 FDA guidelines, and aligned with clinical best practices for adolescent weight management.
Childhood and adolescent obesity affects roughly 20% of young people in the United States. For teens who haven't responded to lifestyle changes alone, GLP-1 medications are increasingly being considered as a treatment option.
But as a parent, you probably have questions. Is it safe? What does the research say? What should you expect?
Here's what you need to know.
FDA-Approved Options for Teens
Wegovy (Semaglutide)
Approved: December 2022 for ages 12+ Indication: Chronic weight management in adolescents with obesity (BMI ≥95th percentile) Dosing: Weekly injection, titrated from 0.25mg to 2.4mg over 16-20 weeks
Saxenda (Liraglutide)
Approved: December 2020 for ages 12+ Indication: Chronic weight management in adolescents with obesity Dosing: Daily injection, titrated from 0.6mg to 3.0mg
Other Medications
Mounjaro/Zepbound (tirzepatide) and Ozempic (semaglutide for diabetes) are not yet FDA-approved for adolescents, though they may be prescribed off-label in some cases.
What the Research Shows
Efficacy in Teens
The STEP TEENS trial (semaglutide for adolescents) showed:
- Average weight loss: 16.1% of body weight at 68 weeks (vs. 0.6% with placebo)
- BMI reduction: Significant improvement in BMI z-score
- Quality of life: Improved physical functioning and quality of life scores
- Cardiometabolic markers: Improved blood pressure, lipids, and blood sugar
These results are comparable to what we see in adults, which is encouraging.
Safety Data in Adolescents
Common side effects (similar to adults):
- Nausea (most common)
- Vomiting
- Diarrhea
- Constipation
- Headache
- Abdominal pain
Serious side effects (rare):
- Gallbladder problems
- Pancreatitis
- Thyroid tumors (seen in rodents; human risk unknown)
- Suicidal thoughts (under investigation)
Key finding: The safety profile in adolescents appears similar to adults. No new or unexpected side effects have emerged in teen populations.
Important Considerations for Parents
1. This Is Not a Quick Fix
GLP-1 medications are intended for chronic weight management, not short-term use. The clinical trials in teens lasted 68 weeks (over a year), and experts expect treatment to continue for years.
2. Lifestyle Changes Still Matter
Medication works best when combined with:
- Healthy eating habits
- Regular physical activity
- Adequate sleep
- Behavioral support
The STEP TEENS trial included lifestyle counseling for all participants.
3. Mental Health Monitoring Is Essential
Adolescence is already a vulnerable time for body image and mental health. Parents should:
- Watch for signs of disordered eating
- Monitor mood changes
- Keep open communication about body image
- Consider therapy alongside medication
See our mental health and GLP-1 guide for more.
4. Insurance Coverage Varies
Coverage for adolescent GLP-1 use is inconsistent:
- Some plans cover it with prior authorization
- Others exclude weight loss medications for minors
- Medicaid coverage varies by state
Check with your insurance before starting.
5. Growth and Development
Parents often worry about whether GLP-1 medications affect growth. Current data suggests:
- Height: No significant impact on growth velocity in trials
- Puberty: No known effects on pubertal development
- Bone health: Adequate nutrition is important; monitor calcium and vitamin D intake
Your pediatrician should monitor growth parameters regularly.
Who Is a Good Candidate?
A teen may be a good candidate for GLP-1 medication if they:
- Are 12 years or older
- Have a BMI at or above the 95th percentile for age and sex
- Have not achieved sufficient weight loss with lifestyle changes alone
- Are motivated to participate in treatment
- Have a supportive family environment
- Do not have contraindications (personal/family history of medullary thyroid cancer, MEN 2, pregnancy)
Questions to Ask Your Teen's Doctor
- "Is my teen a good candidate?"
- "Which medication do you recommend and why?"
- "What side effects should we watch for?"
- "How will we monitor progress?"
- "What happens if we need to stop?"
- "Should we involve a dietitian or therapist?"
- "Will this affect their growth or development?"
- "What does insurance cover?"
The Bottom Line
GLP-1 medications offer a promising option for adolescents struggling with obesity. The research shows meaningful weight loss with a safety profile similar to adults.
But these medications are one part of a comprehensive approach that includes lifestyle changes, family support, and regular medical monitoring.
If you're considering GLP-1 for your teen, start with a conversation with their pediatrician or a pediatric obesity medicine specialist.
This article is for informational purposes only and does not constitute medical advice. Always consult your teen's healthcare provider about their specific situation.
